Document is current
Any future updates will be listed below
-
Authors
Pinato, David J. https://orcid.org/0000-0002-3529-0103
Guerra, Nadia
Fessas, Petros
Murphy, Ravindhi
Mineo, Takashi
Mauri, Francesco A.
Mukherjee, Sujit K.
Thursz, Mark
Wong, Ching Ngar
Sharma, Rohini
Rimassa, Lorenza
-
Funding
Funding for this research was provided by:
Wellcome Trust (PS3416)
Cancer Research UK (C57701/A26137)
AstraZeneca (RSRO_P71752)
Wellcome Trust Clinical Research Training Fellowship
- License Information
-
More Information
Article History
Received: 16 September 2019
Revised: 19 February 2020
Accepted: 25 February 2020
First Online: 10 March 2020
Compliance with ethical standards
:
: DJP received lecture fees from ViiV Healthcare, Roche, Bayer Healthcare and travel expenses from BMS and Bayer Healthcare; consulting fees for Mina Therapeutics, Roche, EISAI; received research funding (to institution) from MSD, BMS. LR received lectures fees from AstraZeneca, AbbVie, Gilead, Roche; advisory board/consulting role fees from Lilly, Bayer, Sirtex Medical, ArQule, Exelixis, Ipsen, Celgene, Eisai, Hengrui Therapeutics, MSD, Baxter, Amgen, Italfarmaco, Sanofi, Incyte; travel expenses from ArQule and Ipsen.
